Smith & Nephew (LON:SN) Share Price Crosses Below 200-Day Moving Average – Here’s Why

Smith & Nephew plc (LON:SN)’s stock price passed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of GBX 1,073.83 ($13.43) and traded as low as GBX 978.20 ($12.24). Smith & Nephew shares last traded at GBX 980.80 ($12.27), with a volume of 1,463,078 shares.

Smith & Nephew Stock Performance

The company’s 50-day moving average is GBX 984.28 and its two-hundred day moving average is GBX 1,073.83. The company has a quick ratio of 0.84, a current ratio of 2.51 and a debt-to-equity ratio of 70.22. The company has a market cap of £8.55 billion, a P/E ratio of 3,632.59, a price-to-earnings-growth ratio of 0.46 and a beta of 0.62.

Insider Activity

In other Smith & Nephew news, insider John Rogers bought 71,920 shares of Smith & Nephew stock in a transaction dated Thursday, December 19th. The stock was purchased at an average price of GBX 972 ($12.16) per share, for a total transaction of £699,062.40 ($874,593.27). Also, insider Deepak Nath sold 34,033 shares of the business’s stock in a transaction that occurred on Thursday, December 5th. The shares were sold at an average price of GBX 981 ($12.27), for a total transaction of £333,863.73 ($417,695.15). Insiders own 0.19% of the company’s stock.

About Smith & Nephew

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.